To achieve this, the president would be evaluating to ignore normal US regulatory standards for this type of procedure. One of the options to reach the goal would involve the Food and Drug Administration (FDA) granting an “emergency use authorization” in October.
United States, August 24 (RT) .— The President of EU, Donald Trump, is considering accelerating the approval of the COVID-19 vaccine being developed by the University of Oxford and the pharmaceutical AstraZeneca, for than is available at country before presidential election, scheduled for November 3, 2020, informs Financial Times, citing three people familiar with the matter.
To achieve this, the leader It would evaluating overlook the regulatory standards EU standards for this type of procedure. One of the options to achieve the goal would involve the Food and Drug Administration (FDA) granting a “authorization of use of emergency” in October.
The availability of the vaccine in the short term would allow to change the image from administration of Trump and your response to the pandemic —Which has already claimed the lives of more than 170 thousand people in the United States— increasing the possibilities of win the upcoming elections.
According to the sources of the newspaper, the comments on this plan were issued by the Chief of Staff of the White House, Mark Meadows, and the Secretary of the Treasury, Steven Mnuchin, in the framework of a meeting with the president of the House of Representatives, Nancy Pelosi, on July 30, where the congresswoman would have warned that “shortcuts” should not be taken in the vaccine approval process.
REFUSAL OF COMMENTS
However, a spokesman for the Secretary of the Treasury referred to the issue and assured that Mnuchin did not comment on the vaccine and “is not aware of any plans either.” He also mentioned that any emerging authorization depends on the FDA.
Meanwhile, from AstraZeneca they stated that “the authorization of emergency use has not been discussed with the US Government”, and that “it would be premature to speculate on that possibility.”
Separately, on Saturday, Trump lashed out at the FDA via Twitter, suggesting they are hindering vaccine trials. “Obviously, they hope to delay the response until after November 3. It must focus on speed and saving lives! ”The president wrote.
Pelosi called the statement “dangerous” to the health of the American people. “The FDA has the responsibility to approve drugs, judging by their safety and efficacy, not by a statement from the White House on the speed and politicization” of the entity, said the congresswoman.
Gallery: IN PHOTOS: Fauci against Trump, when will there be a vaccine for the coronavirus? (Expansion)